| |
| |
|
| Insider
Information: |
Koppikar Utpal |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
187,645 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$125,565 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
187,645 |
|
|
| Total
Value |
$125,565 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Financial Officer |
2023-03-02 |
181,978 |
2018-06-07 |
0 |
Premium* |
|
|
C4 Therapeutics, Inc. |
CCCC |
Director |
2023-02-08 |
5,667 |
2023-02-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
AS |
$3.63 |
$24,921 |
D/D |
(6,871) |
181,978 |
0 |
% |
|
| CCCC |
C4 Therapeutics, Inc. |
Director |
– • – |
2023-02-08 |
4 |
B |
$5.60 |
$31,735 |
D/D |
5,667 |
5,667 |
2.39 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2023-02-07 |
4 |
AS |
$5.46 |
$13,568 |
D/D |
(2,485) |
188,849 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• • – |
2022-11-16 |
4 |
AS |
$4.49 |
$28,086 |
D/D |
(6,255) |
191,334 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• • – |
2022-08-16 |
4 |
AS |
$5.04 |
$29,908 |
D/D |
(5,940) |
197,589 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2022-06-08 |
4 |
AS |
$5.63 |
$32,952 |
D/D |
(5,853) |
203,529 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• • – |
2022-05-17 |
4 |
AS |
$5.32 |
$29,675 |
D/D |
(5,582) |
207,592 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• • – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
61,235 |
216,937 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• • – |
2022-03-01 |
4 |
AS |
$9.86 |
$37,090 |
D/D |
(3,763) |
213,174 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2022-02-07 |
4 |
AS |
$14.46 |
$36,096 |
D/D |
(2,496) |
155,702 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2021-11-16 |
4 |
AS |
$17.12 |
$62,562 |
D/D |
(3,655) |
157,714 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2021-08-17 |
4 |
AS |
$12.53 |
$44,852 |
D/D |
(3,579) |
161,369 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2021-06-08 |
4 |
AS |
$14.06 |
$81,829 |
D/D |
(5,820) |
164,948 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2021-05-18 |
4 |
AS |
$14.55 |
$52,613 |
D/D |
(3,616) |
168,966 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2021-03-26 |
4 |
AS |
$14.58 |
$25,675 |
D/D |
(1,761) |
172,582 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2021-03-02 |
4 |
AS |
$16.74 |
$24,457 |
D/D |
(1,461) |
174,343 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,258 |
175,804 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2021-02-08 |
4 |
AS |
$20.39 |
$35,866 |
D/D |
(1,759) |
130,546 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2020-11-17 |
4 |
AS |
$19.77 |
$29,048 |
D/D |
(1,469) |
132,061 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2020-08-18 |
4 |
AS |
$12.09 |
$18,087 |
D/D |
(1,496) |
133,530 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2020-06-09 |
4 |
AS |
$10.18 |
$39,946 |
D/D |
(3,924) |
135,026 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2020-05-18 |
4 |
AS |
$11.22 |
$16,022 |
D/D |
(1,428) |
137,375 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2020-03-27 |
4 |
AS |
$9.17 |
$16,754 |
D/D |
(1,827) |
137,330 |
0 |
% |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
66,875 |
139,157 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Financial Officer |
• – – |
2020-02-06 |
4 |
AS |
$14.21 |
$25,308 |
D/D |
(1,781) |
72,282 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
